顔面注射市場規模、成長と動向分析レポート 2025-2030年

Facial Injectable Market Growth & Trends

The global facial injectable market size is expected to reach USD 24.9 billion by 2030, registering a CAGR of 12.3% from 2025 to 2030, according to a new report by Grand View Research, Inc., The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

世界の顔面注射市場規模は2030年までに249億米ドルに達し、2025年から2030年にかけて年平均成長率（CAGR）12.3%で成長すると予測されています。顔面注射剤はアンチエイジング治療において極めて重要であり、特に色素沈着や早期老化などのダメージを予防するために使用されています。あらゆる社会経済層で最も人気のある治療法は、ボトックスとフィラーであり、非常に高い人気を誇っています。

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Scope

Facial Injectable Market Report Highlights

• Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures

• Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2024. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines

• Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 47.0% in 2024. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals

• North America dominated the market with a revenue share of 38.9% in 2024 owing to the easy availability of the products and the presence of a large number of skilled surgeons

• The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Segment Definitions

1.2.1. Product

1.2.2. Application

1.2.3. End Use

1.2.4. Regional scope

1.2.5. Estimates and forecasts timeline

1.3. Research Methodology

1.4. Information Procurement

1.4.1. Purchased database

1.4.2. GVR’s internal database

1.4.3. Secondary sources

1.4.4. Primary research

1.4.5. Details of primary research

1.5. Information or Data Analysis

1.5.1. Data analysis models

1.6. Market Formulation & Validation

1.7. Model Details

1.7.1. Commodity flow analysis (Model 1)

1.7.2. Approach 1: Commodity flow approach

1.8. List of Secondary Sources

1.9. List of Primary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Product outlook

2.2.2. Application outlook

2.2.3. End Use outlook

2.2.4. Regional outlook

2.3. Competitive Insights

Chapter 3. Facial Injectable Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.1.1. Increasing beauty consciousness among consumers

3.2.1.2. Shift in consumer preference towards minimally invasive procedures

3.2.2. Market restraint analysis

3.2.2.1. High cost of treatment

3.3. Facial Injectable Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

4.1. Global Facial Injectable Market: Product Dashboard

4.2. Global Facial Injectable Market: Product Movement Analysis

4.3. Global Facial Injectable Market by Product, Revenue

4.4. Collagen & PMMA Microspheres

4.4.1. Collagen & PMMA microspheres market estimates and forecasts 2018 to 2030 (USD Million)

4.5. Botulinum Toxin Type A

4.5.1. Botulinum toxin Type A market estimates and forecasts 2018 to 2030 (USD Million)

4.6. HA

4.6.1. HA market estimates and forecasts 2018 to 2030 (USD Million)

4.7. CaHA

4.7.1. CaHa market estimates and forecasts 2018 to 2030 (USD Million)

4.8. PLLA

4.8.1. PLLA market estimates and forecasts 2018 to 2030 (USD Million)

4.9. Others

4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

5.1. Global Facial Injectable Market: Application Dashboard

5.2. Global Facial Injectable Market: Application Movement Analysis

5.3. Global Facial Injectable Market Estimates and Forecasts, By Application, Revenue (USD Million)

5.4. Facial Line Correction

5.4.1. Facial line correction market estimates and forecasts 2018 to 2030 (USD Million)

5.5. Lip Augmentation

5.5.1. Lip augmentation market estimates and forecasts 2018 to 2030 (USD Million)

5.6. Face Lift

5.6.1. Face lift market estimates and forecasts 2018 to 2030 (USD Million)

5.7. Acne Scar Treatment

5.7.1. Acne scar treatment market estimates and forecasts 2018 to 2030 (USD Million)

5.8. Lipoatrophy Treatment

5.8.1. Lipoatrophy treatment market estimates and forecasts 2018 to 2030 (USD Million)

5.9. Others

5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Facial Injectable Market: End Use Estimates & Trend Analysis

6.1. Global Facial Injectable Market: End use Dashboard

6.2. Global Facial Injectable Market: End use Movement Analysis

6.3. Global Facial Injectable Market Estimates and Forecasts, by End use, Revenue (USD Million)

6.4. MedSpa

6.4.1. MedSpa market estimates and forecasts 2018 to 2030 (USD Million)

6.5. Dermatology Clinics

6.5.1. Dermatology Clinics market estimates and forecasts 2018 to 2030 (USD Million)

6.6. Hospitals

6.6.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)

6.7. Others

6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End use

7.1. Regional Dashboard

7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

7.3. North America

7.3.1. U.S.

7.3.1.1. Key country dynamics

7.3.1.2. Regulatory framework/ reimbursement structure

7.3.1.3. Competitive scenario

7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)

7.3.2. Canada

7.3.2.1. Key country dynamics

7.3.2.2. Regulatory framework/ reimbursement structure

7.3.2.3. Competitive scenario

7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

7.4. Europe

7.4.1. UK

7.4.1.1. Key country dynamics

7.4.1.2. Regulatory framework/ reimbursement structure

7.4.1.3. Competitive scenario

7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)

7.4.2. Germany

7.4.2.1. Key country dynamics

7.4.2.2. Regulatory framework/ reimbursement structure

7.4.2.3. Competitive scenario

7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)

7.4.3. France

7.4.3.1. Key country dynamics

7.4.3.2. Regulatory framework/ reimbursement structure

7.4.3.3. Competitive scenario

7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)

7.4.4. Italy

7.4.4.1. Key country dynamics

7.4.4.2. Regulatory framework/ reimbursement structure

7.4.4.3. Competitive scenario

7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)

7.4.5. Spain

7.4.5.1. Key country dynamics

7.4.5.2. Regulatory framework/ reimbursement structure

7.4.5.3. Competitive scenario

7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)

7.4.6. Norway

7.4.6.1. Key country dynamics

7.4.6.2. Regulatory framework/ reimbursement structure

7.4.6.3. Competitive scenario

7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)

7.4.7. Sweden

7.4.7.1. Key country dynamics

7.4.7.2. Regulatory framework/ reimbursement structure

7.4.7.3. Competitive scenario

7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)

7.4.8. Denmark

7.4.8.1. Key country dynamics

7.4.8.2. Regulatory framework/ reimbursement structure

7.4.8.3. Competitive scenario

7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

7.5. Asia Pacific

7.5.1. Japan

7.5.1.1. Key country dynamics

7.5.1.2. Regulatory framework/ reimbursement structure

7.5.1.3. Competitive scenario

7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)

7.5.2. China

7.5.2.1. Key country dynamics

7.5.2.2. Regulatory framework/ reimbursement structure

7.5.2.3. Competitive scenario

7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

7.5.3. India

7.5.3.1. Key country dynamics

7.5.3.2. Regulatory framework/ reimbursement structure

7.5.3.3. Competitive scenario

7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)

7.5.4. Australia

7.5.4.1. Key country dynamics

7.5.4.2. Regulatory framework/ reimbursement structure

7.5.4.3. Competitive scenario

7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)

7.5.5. South Korea

7.5.5.1. Key country dynamics

7.5.5.2. Regulatory framework/ reimbursement structure

7.5.5.3. Competitive scenario

7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)

7.5.6. Thailand

7.5.6.1. Key country dynamics

7.5.6.2. Regulatory framework/ reimbursement structure

7.5.6.3. Competitive scenario

7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)

7.6. Latin America

7.6.1. Brazil

7.6.1.1. Key country dynamics

7.6.1.2. Regulatory framework/ reimbursement structure

7.6.1.3. Competitive scenario

7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)

7.6.2. Mexico

7.6.2.1. Key country dynamics

7.6.2.2. Regulatory framework/ reimbursement structure

7.6.2.3. Competitive scenario

7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

7.6.3. Argentina

7.6.3.1. Key country dynamics

7.6.3.2. Regulatory framework/ reimbursement structure

7.6.3.3. Competitive scenario

7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)

7.7. MEA

7.7.1. South Africa

7.7.1.1. Key country dynamics

7.7.1.2. Regulatory framework/ reimbursement structure

7.7.1.3. Competitive scenario

7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)

7.7.2. Saudi Arabia

7.7.2.1. Key country dynamics

7.7.2.2. Regulatory framework/ reimbursement structure

7.7.2.3. Competitive scenario

7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

7.7.3. UAE

7.7.3.1. Key country dynamics

7.7.3.2. Regulatory framework/ reimbursement structure

7.7.3.3. Competitive scenario

7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

7.7.4. Kuwait

7.7.4.1. Key country dynamics

7.7.4.2. Regulatory framework/ reimbursement structure

7.7.4.3. Competitive scenario

7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization

8.1.1. Key company market share analysis, 2024

8.1.2. Ispen

8.1.2.1. Company overview

8.1.2.2. Financial performance

8.1.2.3. Product benchmarking

8.1.2.4. Strategic initiatives

8.1.3. Abbvie

8.1.3.1. Company overview

8.1.3.2. Financial performance

8.1.3.3. Product benchmarking

8.1.3.4. Strategic initiatives

8.1.4. Medytox Inc.

8.1.4.1. Company overview

8.1.4.2. Financial performance

8.1.4.3. Product benchmarking

8.1.4.4. Strategic initiatives

8.1.5. Merz GmbH and Co. KGaA

8.1.5.1. Company overview

8.1.5.2. Financial performance

8.1.5.3. Product benchmarking

8.1.5.4. Strategic initiatives

8.1.6. Revance Therapeutics, Inc.

8.1.6.1. Company overview

8.1.6.2. Financial performance

8.1.6.3. Product benchmarking

8.1.6.4. Strategic initiatives

8.1.7. Galderma

8.1.7.1. Company overview

8.1.7.2. Financial performance

8.1.7.3. Product benchmarking

8.1.7.4. Strategic initiatives

8.1.8. Sinclair Pharma

8.1.8.1. Company overview

8.1.8.2. Financial performance

8.1.8.3. Product benchmarking

8.1.8.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation

Table 2 North America Facial Injectable Market, by region, 2018 – 2030 (USD Million)

Table 3 North America Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 4 North America Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 5 North America Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 6 U.S. Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 7 U.S. Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 8 U.S. Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 9 Canada Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 10 Canada Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 11 Canada Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 12 Europe Facial Injectable Market, by region, 2018 – 2030 (USD Million)

Table 13 Europe Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 14 Europe Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 15 Europe Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 16 Germany Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 17 Germany Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 18 Germany Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 19 UK Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 20 UK Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 21 UK Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 22 France Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 23 France Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 24 France Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 25 Italy Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 26 Italy Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 27 Italy Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 28 Spain Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 29 Spain Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 30 Spain Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 31 Denmark Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 32 Denmark Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 33 Denmark Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 34 Sweden Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 35 Sweden Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 36 Sweden Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 37 Norway Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 38 Norway Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 39 Norway Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 40 Asia Pacific Facial Injectable Market, by region, 2018 – 2030 (USD Million)

Table 41 Asia Pacific Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 42 Asia Pacific Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 43 Asia Pacific Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 44 China Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 45 China Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 46 China Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 47 Japan Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 48 Japan Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 49 Japan Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 50 India Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 51 India Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 52 India Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 53 South Korea Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 54 South Korea Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 55 South Korea Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 56 Australia Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 57 Australia Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 58 Australia Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 59 Thailand Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 60 Thailand Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 61 Thailand Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 62 Latin America Facial Injectable Market, by region, 2018 – 2030 (USD Million)

Table 63 Latin America Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 64 Latin America Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 65 Latin America Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 66 Brazil Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 67 Brazil Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 68 Brazil Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 69 Mexico Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 70 Mexico Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 71 Mexico Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 72 Argentina Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 73 Argentina Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 74 Argentina Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 75 MEA Facial Injectable Market, by region, 2018 – 2030 (USD Million)

Table 76 MEA Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 77 MEA Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 78 MEA Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 79 South Africa Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 80 South Africa Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 81 South Africa Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 82 Saudi Arabia Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 83 Saudi Arabia Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 84 Saudi Arabia Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 85 UAE Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 86 UAE Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 87 UAE Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

Table 88 Kuwait Facial Injectable Market, by product, 2018 – 2030 (USD Million)

Table 89 Kuwait Facial Injectable Market, by application, 2018 – 2030 (USD Million)

Table 90 Kuwait Facial Injectable Market, by distribution channel, 2018 – 2030 (USD Million)

List of Figures

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Facial Injectable Market: market outlook

Fig. 9 Facial injectables competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Facial Injectable Market driver impact

Fig. 13 Facial Injectable Market restraint impact

Fig. 14 Facial Injectable Market: Product movement analysis

Fig. 15 Facial Injectable Market: Product outlook and key takeaways

Fig. 16 Collagen & PMMA microspheres market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 17 Botulinum toxin Type A market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 18 HA market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 19 CaHA market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 20 PLLA market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 21 Others market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 22 Facial Injectable Market: Application movement analysis

Fig. 23 Facial Injectable Market: Application outlook and key takeaways

Fig. 24 Facial Line Correction market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 25 Lip augmentation market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 26 Face lift market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 27 Acne scar treatment market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 28 Lipoatrophy treatment market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 29 Others market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 30 Facial Injectable Market: End use movement analysis

Fig. 31 Facial Injectable Market: End use outlook and key takeaways

Fig. 32 MedSpa market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 33 Dermatology clinics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 34 Hospitals market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 35 Global Facial Injectable Market: Regional movement analysis

Fig. 36 Global Facial Injectable Market: Regional outlook and key takeaways

Fig. 37 Global Facial Injectable Market share and leading players

Fig. 38 North America, by country

Fig. 39 North America market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 40 U.S. key country dynamics

Fig. 41 U.S. market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 42 Canada key country dynamics

Fig. 43 Canada market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 44 Europe market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 45 UK key country dynamics

Fig. 46 UK market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 47 Germany key country dynamics

Fig. 48 Germany market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 49 France key country dynamics

Fig. 50 France market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 51 Italy key country dynamics

Fig. 52 Italy market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 53 Spain key country dynamics

Fig. 54 Spain market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 55 Denmark key country dynamics

Fig. 56 Denmark market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 57 Sweden key country dynamics

Fig. 58 Sweden market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 59 Norway key country dynamics

Fig. 60 Norway market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 61 Asia Pacific market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 62 China key country dynamics

Fig. 63 China market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 64 Japan key country dynamics

Fig. 65 Japan market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 66 India key country dynamics

Fig. 67 India market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 68 Thailand key country dynamics

Fig. 69 Thailand market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 70 South Korea key country dynamics

Fig. 71 South Korea market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 72 Australia key country dynamics

Fig. 73 Australia market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 74 Latin America market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 75 Brazil key country dynamics

Fig. 76 Brazil market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 77 Mexico key country dynamics

Fig. 78 Mexico market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 79 Argentina key country dynamics

Fig. 80 Argentina market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 81 Middle East and Africa market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 82 South Africa key country dynamics

Fig. 83 South Africa market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 84 Saudi Arabia key country dynamics

Fig. 85 Saudi Arabia market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 86 UAE key country dynamics

Fig. 87 UAE market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 88 Kuwait key country dynamics

Fig. 89 Kuwait market estimates and forecasts, 2018 – 2030 (USD Million)

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• AIによる信頼、リスク、セキュリティ管理市場規模、成長と動向分析レポート 2025-2030年
• オーディオブック市場規模、成長と動向分析レポート 2025-2030年
• AIデータセンター市場規模、成長と動向分析レポート 2025-2030年
• グリーンテクノロジーと持続可能性市場規模、成長と動向分析レポート 2025-2030年
• 自動運転車市場規模、成長と動向分析レポート 2025-2030年

出版レポート一覧